LU-VE Valuation
Is 0RQV undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0RQV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0RQV (€27.35) is trading above our estimate of fair value (€10.73)
Significantly Below Fair Value: 0RQV is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0RQV?
Key metric: As 0RQV is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 0RQV's PE Ratio? | |
|---|---|
| PE Ratio | 20.5x |
| Earnings | €29.61m |
| Market Cap | €607.34m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.2x |
| Enterprise Value/EBITDA | 10.1x |
| PEG Ratio | 1.3x |
Price to Earnings Ratio vs Peers
How does 0RQV's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 28.1x | ||
JHD James Halstead | 18.6x | 4.1% | UK£771.1m |
FAN Volution Group | 25.7x | 12.1% | UK£1.1b |
GEN Genuit Group | 42.3x | 29.9% | UK£999.3m |
NXR Norcros | 25.6x | 29.5% | UK£228.1m |
0RQV LU-VE | 20.5x | 15.2% | €607.3m |
Price-To-Earnings vs Peers: 0RQV is good value based on its Price-To-Earnings Ratio (20.5x) compared to the peer average (28.3x).
Price to Earnings Ratio vs Industry
How does 0RQV's PE Ratio compare vs other companies in the European Building Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 1 Company | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: 0RQV is expensive based on its Price-To-Earnings Ratio (20.5x) compared to the European Building industry average (19.7x).
Price to Earnings Ratio vs Fair Ratio
What is 0RQV's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 20.5x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 0RQV's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €27.35 | €33.25 +21.6% | 8.0% | €37.00 | €31.25 | n/a | 3 |
| Nov ’25 | €28.05 | €32.27 +15.0% | 10.7% | €37.00 | €28.80 | n/a | 3 |
| Oct ’25 | €26.80 | €32.27 +20.4% | 10.7% | €37.00 | €28.80 | n/a | 3 |
| Sep ’25 | n/a | €31.10 0% | 6.2% | €33.50 | €28.80 | n/a | 3 |
| Aug ’25 | €25.35 | €31.10 +22.7% | 6.2% | €33.50 | €28.80 | n/a | 3 |
| Jul ’25 | n/a | €30.40 0% | 7.2% | €33.50 | €28.80 | n/a | 3 |
| Jun ’25 | n/a | €30.40 0% | 7.2% | €33.50 | €28.80 | n/a | 3 |
| May ’25 | n/a | €30.40 0% | 7.2% | €33.50 | €28.80 | n/a | 3 |
| Apr ’25 | €23.10 | €30.40 +31.6% | 7.2% | €33.50 | €28.80 | n/a | 3 |
| Mar ’25 | €20.50 | €30.00 +46.3% | 8.3% | €33.50 | €28.00 | n/a | 3 |
| Feb ’25 | €23.00 | €30.00 +30.4% | 8.3% | €33.50 | €28.00 | n/a | 3 |
| Jan ’25 | €22.90 | €30.00 +31.0% | 8.3% | €33.50 | €28.00 | n/a | 3 |
| Dec ’24 | €19.90 | €30.00 +50.8% | 8.3% | €33.50 | €28.00 | n/a | 3 |
| Nov ’24 | €17.52 | €33.50 +91.2% | 14.8% | €40.00 | €28.00 | €28.05 | 3 |
| Oct ’24 | €21.60 | €34.70 +60.6% | 10.9% | €40.00 | €31.60 | €26.80 | 3 |
| Sep ’24 | €26.45 | €35.67 +34.8% | 7.0% | €39.00 | €33.00 | n/a | 3 |
| Aug ’24 | €29.60 | €35.67 +20.5% | 7.0% | €39.00 | €33.00 | €25.35 | 3 |
| Jul ’24 | €30.95 | €35.50 +14.7% | 6.4% | €38.50 | €33.00 | n/a | 3 |
| Jun ’24 | n/a | €35.50 0% | 6.4% | €38.50 | €33.00 | n/a | 3 |
| May ’24 | n/a | €35.50 0% | 6.4% | €38.50 | €33.00 | n/a | 3 |
| Apr ’24 | €30.95 | €35.50 +14.7% | 6.4% | €38.50 | €33.00 | €23.10 | 3 |
| Mar ’24 | €31.35 | €32.83 +4.7% | 15.6% | €39.50 | €27.00 | €20.50 | 3 |
| Feb ’24 | €26.80 | €31.43 +17.3% | 18.2% | €39.50 | €27.00 | €23.00 | 3 |
| Jan ’24 | n/a | €31.43 0% | 18.2% | €39.50 | €27.00 | €22.90 | 3 |
| Dec ’23 | €23.95 | €31.43 +31.2% | 18.2% | €39.50 | €27.00 | €19.90 | 3 |
| Nov ’23 | €20.75 | €29.10 +40.2% | 13.3% | €34.50 | €25.60 | €17.52 | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
Senior
UK£577.4m
Designs, manufactures, and sells high-technology components and systems for the principal original equipment manufacturers in the aerospace, defense, land vehicle, and power and energy markets in the United States, the United Kingdom, and internationally.
SNR
UK£1.41
7D
-1.3%
1Y
-18.5%
Aalberts
€3.7b
Offers mission-critical technologies for aerospace, automotive, building, and maritime sectors.
0NX1
€34.40
7D
-0.9%
1Y
-2.2%
Rieter Holding
CHF 384.1m
Supplies systems for manufacturing yarn from staple fibers in spinning mills in Switzerland and internationally.
0QKA
CHF 87.30
7D
-0.9%
1Y
1.2%